Changjiang Lu

发表

Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model

Joseph Mugaanyi, L. Dai, Mingjun Dong, 2022, Scientific Reports.

MMP1 is a Promiseful Prognostic Biomarker and Correlating with Immune Infiltrates in Hepatocellular Carcinoma

Haihong Shi, Tongyue Zhang, Lei Dai, 2021 .

Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma

Joseph Mugaanyi, L. Dai, Caide Lu, 2022, Scientific Reports.

A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas

Tongyue Zhang, Joseph Mugaanyi, L. Dai, 2022, PloS one.

Extended pancreato-duodenectomy coupled with adjuvant chemotherapy for SMARCB1/INI1 deficient pancreatic carcinoma: A case report and literature review

Joseph Mugaanyi, Caide Lu, Changjiang Lu, 2021, International journal of surgery case reports.

Risk Factors of Early Liver Metastasis for Pancreatic Ductal Adenocarcinoma after Radical Resection

Yong Yang, Shengdong Wu, Caide Lu, 2022, Gastroenterology research and practice.

Therapeutic effectiveness and safety of sintilimab-dominated triple therapy in unresectable hepatocellular carcinoma

Joseph Mugaanyi, L. Dai, Caide Lu, 2021, Scientific Reports.

Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma

Hui-zhi Zhang, Changjiang Lu, Zhao-xia Xia, 2021, Journal of clinical laboratory analysis.

A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer

Joseph Mugaanyi, Changjiang Lu, Hai-hong Shi, 2024, BMC women's health.

Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis.

Changjiang Lu, Lei Dai, Yunyan Ye, 2024, Aging.